The machine beeped.
Batch #V-422: Bioavailability at 78%. Target threshold: 80%.
Arjun opened it. The handwriting was in faded Malayalam, but the diagrams were universal. It showed a crude, three-layered tablet. Not a modern matrix system, but a sandwich : a slow-release core, a protective gum from the local kodampuli fruit, and a waxy outer shell made from refined beeswax.
A soft knock broke the silence. It was Meera, the head of formulations, her lab coat smudged with a faint blue stain—the mark of their experimental enteric coating.
Is your company prepared for the cost of downtime?
